Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020
STAMFORD, Conn., Feb. 20, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by...
Read More
